Vascular Biogenics (VBLT) News Today

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Notice: This company has been marked as potentially delisted and may not be actively trading.

Stock Analysis

Source

Source	Headline
	Vascular Biogenics (VBLT) Price Target Increased by 160.00% to 13.26 msn.com - November 3 at 12:39 AM
	Notable Labs Closes Merger Transaction With VBL Therapeutics finance.yahoo.com - October 16 at 3:55 PM
	VBL Therapeutics Announces Results of Annual and Special Shareholder Meeting finance.yahoo.com - October 12 at 3:13 PM
	VBL Therapeutics Reminds Shareholders to Vote in the Upcoming Annual and Special Shareholder Meeting finance.yahoo.com - October 4 at 8:40 AM
	Vascular Biogenics Rises on Presentation Hype finance.yahoo.com - September 9 at 12:00 PM
	VBL Therapeutics Announces that S-4 Registration Statement for Proposed Merger with Notable Labs Is Declared Effective by SEC finance.yahoo.com - September 6 at 7:30 PM
	VASCULAR BIOGENICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Vascular Biogenics Ltd. - VBLT businesswire.com - August 28 at 7:00 PM
	VASCULAR BIOGENICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Vascular Biogenics Ltd. - VBLT businesswire.com - August 28 at 3:04 PM
	VBL Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update finance.yahoo.com - August 14 at 8:09 AM
	Vascular Biogenics (NASDAQ: VBLT) fool.com - July 23 at 5:52 PM
	VBL Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update finance.yahoo.com - May 15 at 8:03 PM
	Vascular Biogenics Stock (NASDAQ:VBLT), Dividends benzinga.com - April 4 at 1:52 AM
	Vascular Biogenics Full Year 2022 Earnings: US$0.42 loss per share (vs US$0.45 loss in FY 2021) finance.yahoo.com - March 17 at 8:38 AM
	VBL Therapeutics Reports Full Year 2022 Financial Results and Provides Corporate Update finance.yahoo.com - March 14 at 9:17 AM
	VBL Therapeutics Announces Closing of Sale of Manufacturing Facility and Certain Related Assets for $7.1 Million in Cash finance.yahoo.com - March 9 at 9:10 AM
	SHAREHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Vascular Biogenics Ltd. - VBLT prnewswire.com - February 27 at 10:12 PM
	VBLT STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Merger of Vascular Biogenics Ltd. Is Fair to Shareholders technews.tmcnet.com - February 23 at 6:48 PM
	SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Vascular Biogenics Ltd. Merger benzinga.com - February 23 at 6:48 PM
	Vascular Biogenics Shares Jump Premarket on Reverse Merger Plans >VBLT marketwatch.com - February 23 at 6:48 PM
	Vascular Biogenics rises 85% on all-stock merger deal with Notable Labs msn.com - February 23 at 6:48 PM
	Why Is Vascular Biogenics (VBLT) Stock Up 52%? investorplace.com - February 23 at 12:09 PM
	marketbeat.com - February 23 at 6:57 AM
	VBL Therapeutics Announces Agreement to Sell Manufacturing Facility and Certain Related Assets for $7.1 Million in Cash finance.yahoo.com - February 16 at 1:06 PM
	OYSTER PT PHARM (OYST) Reports Q3 Loss, Lags Revenue Estimates finance.yahoo.com - November 10 at 7:22 PM
	Axsome (AXSM) Starts Late-Stage Study of Migraine Drug AXS-07 finance.yahoo.com - September 2 at 5:52 PM
	VBL Therapeutics Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency finance.yahoo.com - September 1 at 9:32 PM
	Sorrento (SRNE) Gets FDA Fast Track Tag for Back Pain Product finance.yahoo.com - September 1 at 4:32 PM
	Vascular Biogenics Cutting About 35% of Staff >VBLT marketwatch.com - August 2 at 1:24 PM
	VBL Therapeutics Announces Workforce Reduction finance.yahoo.com - August 2 at 8:23 AM
	Vascular Biogenics (VBLT) Down, Ovarian Cancer Study Fails finance.yahoo.com - July 21 at 3:03 PM
	Gold Prices Settle Lower; Vascular Biogenics Shares Plummet msn.com - July 20 at 6:58 PM
	Why Is Vascular Biogenics (VBLT) Stock Down 80% Today? msn.com - July 20 at 1:54 PM
	Read Why VBL Therapeutics Shares Are Falling To a 52-Week Low finance.yahoo.com - July 20 at 1:54 PM
	VBL Therapeutics Announces Top-Line Data from Phase 3 OVAL Trial of Ofra-Vec in Patients with Platinum-Resistant Ovarian Cancer finance.yahoo.com - July 19 at 8:34 PM
	marketbeat.com - July 19 at 4:04 PM
	Vascular Biogenics (NASDAQ:VBLT) Given "Outperform" Rating at Oppenheimer marketbeat.com - July 18 at 10:44 AM
	Short Interest in Vascular Biogenics Ltd. (NASDAQ:VBLT) Declines By 22.4% marketbeat.com - July 4 at 2:28 AM
	Vascular Biogenics (NASDAQ:VBLT) Upgraded by Zacks Investment Research to Hold marketbeat.com - June 10 at 7:19 AM
	VBL Therapeutics to Participate in the Jefferies Healthcare Conference finance.yahoo.com - May 31 at 11:51 AM
	Q2 2022 EPS Estimates for Vascular Biogenics Ltd. (NASDAQ:VBLT) Decreased by Oppenheimer marketbeat.com - May 20 at 7:35 AM
	Oppenheimer Comments on Vascular Biogenics Ltd.'s Q1 2023 Earnings (NASDAQ:VBLT) marketbeat.com - May 19 at 6:45 AM
	VBL Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update stockhouse.com - May 17 at 11:47 AM
	VBL Therapeutics to Report First Quarter 2022 Financial Results on May 17 finance.yahoo.com - May 10 at 10:41 AM
	What Kind Of Shareholders Hold The Majority In Vascular Biogenics Ltd.'s (NASDAQ:VBLT) Shares? finance.yahoo.com - May 8 at 2:40 PM
	VBL Therapeutics to Participate in Upcoming Scientific and Industry Conferences in May finance.yahoo.com - May 3 at 10:13 AM
	Vascular Biogenics (NASDAQ:VBLT) Now Covered by Analysts at Chardan Capital marketbeat.com - April 28 at 7:07 AM
	The Daily Biotech Pulse: Protagonist's Ulcerative Colitis Study Disappoints, Gilead's Remdesivir Approved For Pediatric COVID-19 Patients, FDA Gives Nod To Gamida's Cell ... msn.com - April 26 at 1:08 PM
	Vascular Biogenics (VBLT) Presents at the KOL Event on Ovarian Cancer - Slideshow seekingalpha.com - April 16 at 11:40 PM
	Zacks Investment Research Lowers Vascular Biogenics (NASDAQ:VBLT) to Sell marketbeat.com - March 29 at 1:53 PM
	VBL Therapeutics Reports Full Year 2021 Financial Results and Provides Corporate Update finance.yahoo.com - March 23 at 9:21 AM

Get Vascular Biogenics News Delivered to You Automatically

Biden’s $374B Giveaway Into This Sector (Ad)

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

VBLT Media Mentions By Week

VBLT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

VBLT
News Sentiment
▼
0.00

0.49
▲
Average
Medical
News Sentiment

VBLT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

VBLT Articles
This Week
▼
0

0
▲
VBLT Articles
Average Week

Get Vascular Biogenics News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:VBLT) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Vascular Biogenics (VBLT) News Today

VBLT Media Mentions By Week

VBLT Media Sentiment

VBLT News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info